相关实验视频

Updated: Feb 25, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

关于ESHRE指南:用于IVF/ICSI的卵巢刺激:2025年更新†

, B Ata^1,2, E Bosch³

¹Department of Obstetrics and Gynaecology, Koc University, Istanbul, Turkey.

Human reproduction (Oxford, England)

|February 24, 2026

概括

这份更新的指南提供了121条关于IVF/ICSI中卵巢刺激的建议,这些建议基于目前的证据. 它解决了改善生育治疗和患者治疗结果的关键问题.

科学领域:

生殖内分泌学生殖内分泌学
在体外受精 (IVF)
细胞内质精子注射 (ICSI) 的方法

背景情况:

以前关于IVF/ICSI卵巢刺激的指导方针是有限的.
欧洲人类生殖和胚胎学会 (ESHRE) 在2019年制定了全面的指导方针.
这一更新包含了新的证据,并解决了卵巢刺激的不断变化的方面.

研究的目的:

在IVF/ICSI中提供基于证据的卵巢刺激建议.
为了回答有关患者管理的关键临床问题.
引导临床医生优化治疗疗效和安全.

主要方法:

开发遵循ESHRE指南的结构化方法.
关键问题被修订,新问题被添加,现有的问题被改进.
审查了2018年10月至2025年2月期间发表的文献,重点关注活产率和卵巢过度刺激综合征 (OHSS).

主要成果:

该指南包括121条建议:42条不变,4条修订,29条更新和46条新建议.
建议涵盖了刺激前评估,疗法,垂体抑制,刺激,监测,触发卵细胞成熟,白细胞支持,OHSS预防和生育能力的保护.
大多数基于证据的建议质量低至非常低,很少有中等质量的发现.

结论:

该指南为临床医生提供了关于卵巢刺激最佳实践的明确建议.
新的干预措施往往缺乏足够的研究,导致反对使用或进一步研究的建议.
提供了一份研究建议清单,以指导未来对卵巢刺激的研究.

关键词:

埃斯赫雷埃斯赫雷是一个人.美国国务院调查局 (ICSI)在这个过程中,IVF IVF.保护生育能力保护生育能力准则准则准则高响应的高响应者捐赠卵子细胞捐赠卵巢过度刺激综合征是什么卵巢刺激卵巢刺激糟糕的响应者响应者

更多相关视频

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Author Spotlight: Evaluating the Impact of Immediate Partial Removal of Cumulus-Oocyte Complexes on Fertilization Efficiency and Embryo Quality

Author Spotlight: Evaluating the Impact of Immediate Partial Removal of Cumulus-Oocyte Complexes on Fertilization Efficiency and Embryo Quality

Published on: October 18, 2024

相关概念视频

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

Infertility in Females

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...

Meiosis II

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...